0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > SLITRK6

SLITRK6

Brief Information

Name:SLIT and NTRK-like protein 6
Target Synonym:SLITRK6,SLIT And NTRK Like Family Member 6,SLIT And NTRK-Like Family, Member 6,SLIT And NTRK-Like Protein 6,Slit And Trk Like Gene 6,4832410J21Rik,DFNMYP,FLJ22774
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

SL6-H52H9-ELISA
 SLITRK6 ELISA

Immobilized Human SLITRK6, His Tag (Cat. No. SL6-H52H9) at 10 μg/mL (100 μL/well) can bind Sirtratumab with a linear range of 0.5-31 ng/mL (QC tested).

SL6-H52H9-MALS-HPLC
SLITRK6 MALS images

The purity of Human SLITRK6, His Tag (Cat. No. SL6-H52H9) is more than 90% and the molecular weight of this protein is around 70-90 kDa verified by SEC-MALS.

Synonym Name

SLITRK6

Background

SLIT and NTRK-like protein 6 (SLITRK6) belongs to the SLITRK family. SLITRK6 contains 11 LRR (leucine-rich) repeats, two LRRCT domains and two LRRNT domains. In adult brain, SLITRK6 is highly expressed in putamen and also is expressed in adult, fetal lung and fetal liver. SLITRK6 is also expressed at high levels in some brain tumors. Overexpression of SLITRK6 inhibites neurite outgrowth in cultured neurons.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
sirtratumab vedotin AGS-15E; ASG-15ME; AGS15C–SGD-1006; Ha15-10ac.1vcMMAE; Ha15-10ac12vcMMAE Phase 1 Clinical Agensys Inc Carcinoma, Transitional Cell Details
sirtratumab vedotin AGS-15E; ASG-15ME; AGS15C–SGD-1006; Ha15-10ac.1vcMMAE; Ha15-10ac12vcMMAE Phase 1 Clinical Agensys Inc Carcinoma, Transitional Cell Details

This web search service is supported by Google Inc.

totop

Nachricht schicken